Brief: Fusen Pharmaceutical Company Ltd Expects To Record Profit Attributable Of RMB63 Mln To RMB75 Mln For Year
08/03/2021 14:47
March 8 (Reuters) - Fusen Pharmaceutical Co Ltd 1652.HK :
* EXPECTS TO RECORD PROFIT ATTRIBUTABLE OF RMB63 MILLION TO
RMB75
MILLION FOR YEAR
* EXPECTED RESULT DUE TO INCREASE IN SALES OF
SHUANGHUANGLIAN ORAL
SOLUTIONS
Source text for Eikon: ID:nHKS6mCGwD
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA